...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM Voting

Zenith is potentially worth multiple billions to other pharmas.  $2 may be good for you but I expect fair value. 

Share
New Message
Please login to post a reply